Skye Bioscience Inc
General ticker "SKYE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $143.8M
Skye Bioscience Inc does not follow the US Stock Market performance with the rate: -15.6%.
Estimated limits based on current volatility of 7.2%: low 2.59$, high 2.99$
Short-term SKYE quotes
Long-term SKYE plot
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $13.67MM |
| Operating Income | $-13.67MM |
| Non-Operating Income | $-23.97MM |
| Interest Expense | $0.91MM |
| R&D Expense | $5.82MM |
| Income(Loss) | $-37.64MM |
| Taxes | $0.00MM |
| Profit(Loss) | $-37.64MM |
| Stockholders Equity | $-2.13MM |
| Inventory | $0.76MM |
| Assets | $11.94MM |
| Operating Cash Flow | $-13.95MM |
| Capital expenditure | $0.01MM |
| Investing Cash Flow | $6.60MM |
| Financing Cash Flow | $16.44MM |
| Earnings Per Share* | $-5.37 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.